Corrections & Amplifications -- WSJ
April 20 2018 - 3:02AM
Dow Jones News
This article is being republished as part of our daily
reproduction of WSJ.com articles that also appeared in the U.S.
print edition of The Wall Street Journal (April 20, 2018).
Merck KGaA's products include Femibion, a supplement for women.
A Business News article in some editions Thursday about the sale of
Merck KGaA's consumer-health unit to Procter & Gamble Co.
incorrectly called the product Febimion.
Readers can alert The Wall Street Journal to any errors in news
articles by emailing wsjcontact@wsj.com or by calling
888-410-2667.
(END) Dow Jones Newswires
April 20, 2018 02:47 ET (06:47 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From Sep 2023 to Sep 2024